Real‐world comparison of all‐cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for NVAF patients prescribed oral anticoagulants in a US health plan

Abstract Authors: Amin A, Keshishian A, Vo L, Zhang Q, Dina O, Patel C, Odell K, Trocio J. Aims: To compare the risk of all-cause hospitalization and hospitalizations due to stroke/systemic embolism (SE) and major bleeding, as well as associated healthcare costs...

Real‐world rates, predictors and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: Results of a pooled analysis of six retrospective observational studies

Abstract Authors: Xie L, Wei W, Pan C, Baser O. Objective: To evaluate the real-world rates of hypoglycemia and related costs among patients with type 2 diabetes mellitus (T2DM) who initiated insulin glargine with either a disposable pen or vial-and-syringe....